Alternatives to Pristima

We streamline the intricacies involved in managing your complete product lifecycle. Designed for user-friendliness and flexibility to meet your organization’s specific requirements, STARLIMS lab informatics solutions cater to the evolving demands of data management throughout your organization. Our laboratory information management systems (LIMS software) can seamlessly connect with your existing infrastructure, while also pinpointing areas for process enhancement, enabling you to accelerate the market introduction of high-quality and safe products. In doing so, we empower your organization to thrive in a competitive landscape.

All-in-One LIMS, ELN, QMS, and DMS Platform Xybion LIMS is an all-inclusive Digital Laboratory system including LIMS, ELN, QMS, and DMS that creates optimized workflows for the unique business needs of all regulated laboratories including research, diagnostics, quality control, stability studies, and more. Xybion LIMS instills consistency, improves data quality, and supports regulatory compliance with a complete laboratory management solution that connects with your operating systems with powerful laboratory information management and analytics.

Many Contract Research Organizations (CROs), as well as drug developers, who conduct toxicology studies internally or externally, find it challenging and critical to consolidate and validate data sets. Savante allows your organization to create, merge and validate preclinical study data from any source. Savante allows scientists and managers to view preclinical data in SEND format. The Savante repository automatically syncs preclinical data from Pristima XD. Data from other sources can also be merged through import and migration, as well as direct loads of data sets. The Savante toolkit handles all the necessary consolidation, study merging and control terminology mapping.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

At Metabolon, we proudly provide the most extensive Level 1 library in the metabolomics field. Our unique library has been meticulously developed and refined over two decades, boasting more than 5,400 entries. The majority of these entries are classified as Level 1, comprising roughly 85% (around 4,600 entries); however, about 15% of the library consists of Level 2 entries (approximately 800 entries), which are categorized as such due to the unavailability of commercial standards necessary for Level 1 classification. Thanks to our unparalleled library size and exceptional annotation confidence, Metabolon offers precise and highly actionable insights tailored to our clients’ scientific or clinical needs. The applications of metabolomics span a broad spectrum of research areas, including soil health, nutritional studies, preclinical investigations, and clinical trials. Whether you're identifying trends within a population or fine-tuning an individual's treatment plan, metabolomics serves as a powerful tool to uncover crucial answers to pressing questions in various fields. With such extensive resources at your disposal, the potential for discovery is truly limitless.

Clindata Cloud gathers pre-clinical, clinical, and Risk Metric data from various sources and provides the clinical operations teams with data sets that are ready for submission, along with analytics and alerts for risk-based monitoring. It integrates and harmonizes study data from different origins into a unified data model, ensuring that the incoming data is validated for factors such as completeness, accuracy, integrity, and consistency while also raising alerts for any anomalies or risk indicators. Data is standardized according to CDISC data standards to reduce noise and facilitate the creation of ready-to-submit data sets in real-time, allowing for ongoing validation and analysis. Additionally, it produces real-time analytics based on the standardized data, ensuring timely insights for clinical decision-making. This comprehensive approach enhances the efficiency and reliability of clinical operations.

Introducing an integrated suite of professional tools designed to facilitate dynamic sharing of pre-clinical study data globally, featuring advanced capabilities and widely recognized industry standards. The Seralogix Study Manager™ platform seeks to create a standardized and efficient process for managing pre-clinical studies through a user-friendly interface. It caters to both individual researchers and large-scale research enterprises, harnessing powerful computational resources to simplify experimental design, data collection, and reporting. With this set of tools, you and your team can be assured of high data quality while reaping the advantages of immediate reporting. Successfully planning your experimental design can often feel overwhelming, but Seralogix Study Manager guides you through each step necessary to achieve the statistical rigor required for the success of your studies, ultimately transforming the way research is conducted. As you navigate this innovative platform, you'll discover how it can enhance collaboration and elevate the overall quality of research outcomes.

Experience seamless collaboration and knowledge sharing across your organization with a comprehensive platform that integrates all essential tools, allowing for secure workflows and the use of Phoenix-based applications alongside third-party software. With more than 6,000 researchers relying on Phoenix WinNonlin for non-compartmental analysis (NCA), toxicokinetic modeling, and pharmacokinetic and pharmacodynamic (PK/PD) modeling, it has become the preferred choice among biopharmaceutical companies, academic institutions, and 11 international regulatory bodies, including the US FDA, EMA, and PMDA. Additionally, the Phoenix Platform offers advanced features like population PK/PD (popPK) modeling through Phoenix NLME and Level A correlation capabilities provided by the Phoenix IVIVC Toolkit, while its Validation Suites enable rapid software validation in less than half an hour, ensuring efficiency and compliance. This powerful suite not only enhances research productivity but also fosters innovation by enabling users to streamline their workflows effectively.

Discover valuable insights within your data by utilizing the Cortellis™ suite of life science intelligence tools, enabling you to make more informed decisions throughout the entire R&D process. We have alleviated the burden of gathering, integrating, and analyzing data, allowing you to concentrate on the essential choices necessary for expediting your products' market entry. With a unique combination of extensive, high-quality data, fortified by profound domain knowledge, industry insight, and therapeutic expertise, Cortellis reveals crucial insights that facilitate data-driven decisions, ultimately speeding up innovation. Access tailored, actionable responses to your specific inquiries throughout the R&D lifecycle, drawing from the most comprehensive and in-depth intelligence sources available. By incorporating Cortellis into your daily routine, you can significantly enhance the pace of innovation and streamline your workflow. This makes Cortellis not just a tool, but a vital partner in your path to success.

PharmaPendium serves as a robust platform that grants users access to a wide array of FDA and EMA drug approval documents, encompassing essential aspects like pharmacokinetics, pharmacodynamics, and safety evaluations. This resource delivers in-depth insights into drug-drug interactions, side effects, and outcomes from clinical studies, thereby empowering stakeholders to make well-informed decisions during the drug development process and when making regulatory submissions. Its rich database aids researchers and healthcare practitioners in assessing both the efficacy and safety of medications, playing a pivotal role in the progression of pharmaceutical research and enhancing patient care. Users can explore historical regulatory submissions and leverage past precedents to better understand and anticipate agency requirements. The interface allows for a seamless transition from tabular data to dynamic charts, graphs, and other visual tools, making it easier to analyze and interpret findings. Additionally, users can search for information related to adverse events (MedDRA), therapeutic targets, drug indications, and endpoints utilizing standardized data. Result pages effectively connect preclinical research with clinical applications, facilitating a comprehensive understanding of the drug development landscape. Overall, this platform not only streamlines the research process but also fosters collaboration and knowledge-sharing among industry professionals.

Why is HORIZON ranked among the top 10 LIMS softwares? HORIZON was designed by lab managers and is an affordable LIMS platform that can be configured and integrated with any type of lab. It is not enough to consider a laboratory information management system an afterthought. It is too important to be forgotten. There is a better option. HORIZON LIMS was designed by and for its users. HORIZON is easily integrated and can be configured to adapt to any lab's existing systems. HORIZON was designed to seamlessly integrate with existing workflows, so there is minimal disruption and fast implementation. HORIZON gives you results that you can see right away. A team of problem solvers supports our intuitive interface. HORIZON was developed by lab professionals. We understand what you need in order to deliver results. HORIZON has expert support and implementation teams that will ensure your system runs smoothly into the future.

Pluto was founded in 2021 by the Wyss Institute of Harvard University. It has been a trusted partner for many life sciences organizations across the country, from biotech start-ups and public biopharma companies. Our cloud-based platform allows scientists to manage all their data, run bioinformatics analysis, and create interactive visualizations that are published-quality. The platform is being used for a variety of biological applications. These include preclinical and translational science research, cell and gene therapies and drug discovery and development.

Mantarray revolutionizes the early phases of preclinical drug testing by integrating functional data with advanced technologies. By enabling simultaneous analysis of 3D engineered muscle tissues that exhibit adult-like functional characteristics, Mantarray facilitates the identification, safety assessment, and effectiveness evaluation of new therapeutics. With an impressive tissue formation success rate exceeding 95%, the Mantarray Plate Kit ensures consistent and reproducible engineered tissues across 24 wells. This innovative platform offers a user-friendly, scalable, and adaptable solution that empowers researchers to analyze 3D tissues in vitro right within their labs. Early adopters can take advantage of this groundbreaking instrument. The Mantarray system employs a unique magnetic sensing method that accurately detects the contractions of engineered muscle tissues (EMTs), allowing users to assess the contractility of 24 tissues simultaneously and in real time, greatly enhancing throughput. Moreover, the accompanying software simplifies the process by eliminating the need for manual contractility calculations, thus streamlining the research workflow. Overall, Mantarray not only improves the efficiency of drug discovery but also enhances the reliability of data obtained during preclinical studies.

Chemia is an innovative ELN platform that operates in the cloud and via browsers, specifically tailored by scientists for their peers. This platform facilitates the management, assignment, monitoring, and documentation of all research and development endeavors from a single intuitive dashboard. It transforms your R&D processes into entirely paperless operations, drastically improving efficiency by saving approximately one hour per scientist through enhanced cross-functional collaboration. Additionally, Chemia ensures that your lab remains audit-ready and manages data with utmost precision. The platform allows for quick retrieval, efficient searching, comparative studies, and reconfigurability, which in turn supports faster and more informed decision-making. Furthermore, Chemia includes an inventory management system that systematically organizes, maintains, and schedules essential information regarding chemicals and equipment utilized in the laboratory. It also offers detailed logs for equipment usage, maintenance, and calibration, which contribute to optimal lab management and productivity. Lastly, the system provides established protocols to ensure compliance with regulatory standards, thereby reinforcing operational integrity.

By fostering robust partnerships with top Contract Research Organizations (CROs), we provide an innovative approach to the secure onboarding and evaluation of research studies. Our exceptional user experience in study management and image analysis, combined with integrated artificial intelligence, greatly enhances the productivity of our pathologists. The cutting-edge cloud-based system facilitates immediate collaboration between pharmaceutical companies and CRO partners globally, regardless of location. Users maintain comprehensive control over the configuration of their studies, accommodating various types of associated data, study sizes, and formats from Whole Slide Imaging (WSI) vendors, including capabilities for SEND data representation and LIMS integration, all presented through an easy-to-navigate interface. We combine efficient workflow design, outstanding viewing performance, and user-friendliness to create a distinctly superior digital pathology experience. Patholytix Preclinical stands as a fully scalable solution that adapts to the evolving needs of your organization, ensuring seamless access to studies whether in the office or working remotely. This adaptability not only enhances operational efficiency but also empowers teams to collaborate more effectively in a rapidly changing research landscape.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

Scitara DLX™ provides a swift connectivity framework suitable for any instrument found within life science laboratories, all while operating on a cloud-based platform that is both compliant and auditable. As a versatile digital data infrastructure, Scitara DLX™ facilitates connections between various instruments, resources, applications, and software utilized in the lab. The comprehensive cloud system ensures that all data sources are interconnected, promoting seamless data movement across numerous endpoints. Consequently, researchers can concentrate on their scientific endeavors instead of being bogged down by data-related challenges. Moreover, DLX intelligently curates and corrects data as it is processed, fostering the creation of accurate and well-organized data models that are essential for enhancing AI and ML systems. This robust approach plays a vital role in advancing digital transformation strategies within the pharmaceutical and biopharmaceutical sectors. By unlocking valuable insights from scientific data, the platform accelerates decision-making processes in drug discovery and development, ultimately aiding in the expedited launch of new medications into the market. Additionally, the integration of such a sophisticated infrastructure not only streamlines workflows but also enhances collaboration among researchers, paving the way for innovative solutions in the life sciences field.

LabRelations is an innovative and adaptable laboratory platform designed to consolidate and optimize scientific and testing workflows by integrating essential modules like LIMS, ELN, CTMS, and EDC into a cohesive system that facilitates everything from sample tracking and experiment logging to study oversight and compliance reporting. This comprehensive tool not only minimizes manual tasks, inaccuracies, and data fragmentation but also allows laboratories to house all their information in one centralized location. Users can establish rule-based workflows and automations, link instruments and outside systems, as well as ensure complete audit trails and adherence to regulations such as GxP and 21 CFR. Furthermore, LabRelations provides the flexibility to tailor objects, forms, views, and permissions to meet the unique requirements of each lab, thereby enhancing collaboration across various functions and offering real-time insights spanning from research and quality assurance to clinical studies and highly regulated settings. As a result, this platform significantly elevates the efficiency and reliability of laboratory operations.

Thermo Scientific Amira Software serves as a robust and versatile solution for visualizing, analyzing, and comprehending life science and biomedical research data across a range of imaging modalities, such as optical and electron microscopy, CT, MRI, and more. Notably efficient and adaptable, Amira Software enhances advanced bioimaging workflows in diverse research domains, including structural biology, cellular biology, tissue imaging, neuroscience, preclinical studies, and bioengineering. Among its standout features are capabilities for importing and processing image data, visualization and exploration, sophisticated segmentation, measurement, quantification, and analysis, as well as tailored tools for molecular visualization, object tracking, filament tracing, meshing for finite element analysis, diffusion tensor imaging, 3D registration, and the analysis of biomaterial deformation. Additionally, Amira Software provides options for customization and integrates seamlessly with ecosystems like MATLAB, Python, and custom C++, making it a highly adaptable tool for researchers. This flexibility ensures that researchers can tailor their workflows to meet specific experimental needs and challenges.

Sarjen provides an integrated Clinical Trial Management System (CTMS) and Bioanalytical LIMS designed to support complete digital transformation across early-phase and late-phase clinical research. The platform brings clinical operations, site management, subject tracking, financial oversight, and laboratory sample lifecycle management into one unified ecosystem, giving sponsors, CROs, and research teams full visibility and control over their studies. With a user-friendly interface and configurable workflows, it simplifies complex processes while maintaining strict regulatory compliance and data integrity. Built as an AI-enabled solution, the software leverages advanced analytics and machine learning to improve operational efficiency and decision-making. Intelligent dashboards deliver real-time insights, predictive enrollment forecasting helps optimize recruitment strategies, and automated risk detection highlights potential delays or data inconsistencies before they impact study timelines. AI-driven query management and anomaly detection in bioanalytical data reduce manual effort and enhance accuracy across trial and laboratory operations. By combining automation, centralized data management, and smart reporting, the platform accelerates study startup, improves collaboration between clinical and lab teams, and ensures audit readiness at every stage. Through innovation, AI, and transformation-focused design, it empowers organizations to conduct faster, smarter, and more reliable clinical research while confidently navigating the evolving demands of global trials.

Discngine Assay serves as a comprehensive laboratory informatics platform that unifies all stages of plate-based assays into a streamlined, compliant, and effective workflow, proving to be a vital resource for screening research laboratories. This platform empowers researchers to optimize their entire High Throughput Screening process, encompassing everything from managing samples and analyzing assay data to data storage and qualifying liquid handling instruments. With its user-friendly interface and powerful API, Discngine Assay integrates effortlessly with laboratory equipment and the existing IT infrastructure, facilitating effective data collection and processing. Tailored to expedite the discovery of new molecules, it meets the requirements of the pharmaceutical, biotech, and contract research organization sectors, thereby promoting collaboration and fostering innovation within life sciences research. Furthermore, its ability to adapt to various laboratory environments makes it a versatile solution for evolving research demands.

To expedite innovative breakthroughs and swiftly bring products to market, research and development alongside manufacturing facilities must adapt and modify their processes in real time. Data management should never become a hindrance in this dynamic landscape. The Thermo Scientific™ Nautilus LIMS™ for Dynamic Discovery and R&D Environments, co-developed with clients operating in rapid R&D contexts, offers a highly adaptable and user-friendly system that enhances workflow efficiency, increases throughput, and ensures data accuracy while streamlining administrative tasks, sample tracking, and adherence to regulatory standards. Its automated management of intricate boards and specialized graphics tools simplifies data oversight, allowing even less experienced users to easily identify and monitor processes. Clients are empowered to design workflows, track the life cycles of samples, and automate interactions across various platforms while seamlessly incorporating regulated protocols that conform to good laboratory practices and the 21 CFR Part 11 regulations. This innovative approach not only fosters a more efficient research environment but also encourages collaboration and creativity among teams.

The in-system protocol serves as a comprehensive training program, integrated with fingerprint attendance for enhanced security. Cronos offers highly customizable workflows tailored for conducting various studies such as dermal, patch, and other bioavailability-bioequivalence (BA-BE) or early-phase research. It enables the capture, cleansing, and efficient management of study data, whether sourced from paper-based or electronic data capture (EDC) trials. Additionally, users can extract data into preferred datasets in compliance with industry standards like CDISC (SDTM). The EDC tool features real-time activity monitoring, and its Bedside Data Collection capabilities facilitate quicker, paperless assessments. Furthermore, Cronos includes a sample inventory and tracking system, ensuring a compliance-ready data repository. It supports data e-printing from nearly all BA instruments and software, along with an online review process complete with e-stamping and e-signatures within a defined workflow. Users can view projects, export, and archive data efficiently while generating high-quality statistical reports, tables, listings, and formats in both fixed and customizable layouts with remarkable ease. This robust system not only streamlines the research process but also enhances overall data integrity and accessibility.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Data flows in from various channels, including EDC, EHR, smartphones, mobile devices, and central laboratories. Prism expertly integrates this diverse information and transforms it into usable knowledge. By combining user-friendliness with cutting-edge features, Prism EDC presents a modern approach to collecting and managing clinical trial data. Beyond traditional form-based data gathering, Prism also consolidates and organizes information from a wide range of sources. Additionally, Prism eSource offers a groundbreaking software solution that enables research teams to directly pull clinical trial data from a site's electronic health record (EHR). This innovation not only enhances efficiency and reduces costs compared to the existing model—where sites redundantly input the same data into multiple systems—but also speeds up the availability of new therapies to patients in need. As a result, the healthcare industry stands to benefit significantly from the streamlined processes that Prism facilitates.

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

3decision® serves as a cloud-based repository for protein structures, focusing on efficient management of structural data and offering sophisticated analytics to support teams involved in the discovery of small molecules and biologics, thereby expediting the process of structure-based drug design. The platform consolidates and standardizes both experimental and computational protein structures sourced from publicly available databases such as RCSB PDB and AlphaFoldDB, in addition to proprietary datasets, and accommodates formats like PDBx/mmCIF and ModelCIF. This comprehensive approach guarantees seamless access to a variety of structural formats including X-Ray, NMR, cryo-EM, and modeled structures, thereby promoting collaboration and bolstering research initiatives. In addition to its storage capabilities, 3decision® enhances each entry with valuable metadata and sequence information, which encompasses details on protein-ligand interactions, antibody annotations, and specifics about binding sites. Equipped with advanced analytical instruments, the platform is capable of pinpointing druggable sites, evaluating off-target risks, and facilitating comparisons of binding sites, which collectively transform extensive structural datasets into practical insights that can drive research forward. Furthermore, its cloud-based architecture fosters enhanced collaboration among research teams, making it easier for scientists to share findings and insights, ultimately leading to more innovative approaches in drug discovery and development.

We offer a comprehensive tracking solution designed specifically for clinical trials. With a simple download onto your trial managers' mobile devices, you can relax as TruLab's advanced blockchain technology handles all the complexities. There's no need to wait for samples to arrive at a central lab to identify potential issues; instead, you can detect data anomalies in real-time as samples progress through the clinical trial process. TruLab facilitates continual remote accessioning of samples, addressing the significant concern that 20% of samples are either lost or deemed unusable during late-stage trials. This situation is unacceptable from ethical, logistical, and financial perspectives. Furthermore, with sample collections increasingly taking place at participants' homes, new challenges in tracking these samples arise. TruLab effectively monitors samples wherever they are located, ensuring that they are accounted for from residences to repositories, thus enhancing the overall integrity of the clinical trial process. By providing seamless tracking capabilities, TruLab empowers trial managers to mitigate risks and improve outcomes.

Amazon Bio Discovery is an innovative application leveraging AI to enhance the efficiency of early-stage drug discovery by fusing computational biology models with practical laboratory testing in a cohesive "lab-in-the-loop" approach. This tool empowers researchers by granting them immediate access to an extensive library of biological foundation models developed from vast biological datasets, facilitating the rapid generation and assessment of potential drug candidates, including antibodies, with improved accuracy and speed. Additionally, the platform features an integrated AI agent that allows users to engage in natural language conversations to choose suitable models, set up experiments, and fine-tune inputs, eliminating the need for advanced programming skills or complex infrastructure. Researchers can also create multi-step workflows that integrate various models, evaluate their efficacy, and share workflows among teams, thereby fostering better collaboration between computational biologists and laboratory scientists. Ultimately, this powerful tool aims to streamline the drug discovery process and enhance scientific innovation in the field.

Historically, managing clinical trials at investigator sites involved either the cumbersome task of maintaining numerous shared spreadsheets or investing in costly software that often did not fit the Australian context. MAISi represents a revolutionary shift in this landscape. Originating in 2001 as a data repository for clinical trials at a prominent hospital, MAISi has transformed into an advanced workflow application designed to streamline various functions within research units. Serving as a centralized database, MAISi efficiently organizes information related to studies and the corresponding business units that manage them. This structured approach enhances management decision-making capabilities. Individual staff members within each business unit can access specific data pertaining to their studies, patients, investigators, and study team members, while those with broader access rights, typically Financial Officers and System Administrators, can view comprehensive data across all units. Additionally, this streamlined access promotes collaboration and improves overall operational efficiency.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.

Harness the capabilities of artificial intelligence to accelerate the transition from laboratory research and experimental findings to the introduction of transformative therapies. Achieve a remarkable increase in research efficiency, potentially improving productivity by as much as 90% by cutting down your literature review time from several months to mere minutes. Eliminate distractions and enhance your search capabilities with a precise and accurate tool that simplifies the navigation of the expanding landscape of scientific publications. This approach not only saves time but also minimizes bias and enhances the likelihood of discovering groundbreaking insights. Delve deeply into the intricacies of disease biology and engage in sophisticated target identification. Causaly's advanced knowledge graph integrates data from countless publications, enabling thorough and objective scientific investigations. Effortlessly explore the intricate biological cause-and-effect dynamics without requiring extensive expertise. Access a comprehensive array of scientific documents and reveal previously overlooked connections. Causaly’s robust AI system processes millions of biomedical articles, facilitating improved decision-making and enhancing research outcomes, ultimately leading to a more informed and innovative scientific community. By utilizing such tools, researchers can significantly transform their methodologies and enhance their contributions to medicine.

Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.

Embark on a journey towards enhanced data integrity and assured decision-making with Clinical Ink. As trailblazers in the realm of eSource, their technological framework and service offerings ensure increased reliability from the initial source all the way to submission. Discover Lunexis™, a well-defined and interconnected eSource Ecosystem that provides targeted data capture solutions tailored to your protocol during the pivotal moments that count. The Lunexis platform simplifies the deployment of a cohesive and user-friendly eSource solution, granting you access to your study data anytime and anywhere. We offer more than just rapid and accurate data; we instill assurance in your processes. With this approach, both your sites and patients benefit from a smoother experience, leading to improved patient compliance and engagement, as well as ensuring proper protocol execution. Take the first step toward successfully managing your most intricate studies with confidence — utilize Lunexis to facilitate informed and optimal decision-making for your research endeavors. Moreover, this innovative platform not only streamlines processes but also enhances collaboration among all stakeholders involved in the study.

We provide a range of solutions, from straightforward turnkey options to extensive multi-site research projects, assisting principal investigators in navigating the typical challenges associated with database configuration and selection. Researchers frequently turn to QuesGen for expert guidance on optimal data management practices and for supplementary services that facilitate the swift launch of their studies. As a seasoned collaborator for numerous academic institutions and researchers, we excel in handling sizable datasets and performing data curation through our adaptable data platform. This capability allows for the rapid and seamless initiation and expansion of research projects. With an all-encompassing data model, a library of assessments, and expertise in curation, QuesGen is dedicated to ensuring that you are operational quickly while guaranteeing high-quality, compliant data, enabling you to concentrate on analyzing your findings. Our solutions support various clinical research efforts within your organization, adhering to HIPAA and FDA 21 CFR Part 11 requirements, and they can seamlessly integrate with your electronic medical records system and the Federal Interagency TBI Repository (FITBIR). By leveraging our services, researchers can enhance their efficiency and streamline their workflows, ultimately leading to more impactful research outcomes.

Eidogen-Sertanty's Target Informatics Platform (TIP) stands out as the pioneering structural informatics system and knowledgebase that empowers researchers to explore the druggable genome through a structural lens. By harnessing the burgeoning wealth of experimental protein structure data, TIP revolutionizes structure-based drug discovery, shifting it from a limited, low-throughput field to a dynamic and data-rich scientific discipline. It is specifically designed to connect the realms of bioinformatics and cheminformatics, providing drug discovery scientists with a repository of insights that are not only unique but also highly synergistic with the information available from traditional bio- and cheminformatics tools. The platform's innovative combination of structural data management with advanced target-to-lead calculation and analytical capabilities significantly enhances every phase of the drug discovery process. With TIP, researchers are better equipped to navigate the complexities of drug development and make informed decisions.

We developed Viewics to address the challenge of making healthcare data more insightful and relevant. Our platform is designed with safety and security in mind while possessing the capability to revolutionize organizations. The Viewics Platform serves as a comprehensive healthcare analytics solution that reveals actionable insights, enabling enhancements in patient care, operational efficiency, and financial performance both in the lab and throughout the healthcare spectrum. With preconfigured alerts for key laboratory performance indicators, users receive proactive notifications when important thresholds are reached, resulting in greater transparency and control. Customized dashboards cater to individual user preferences, showcasing only the most pertinent data to enhance user experience and encourage ongoing engagement with the platform. Additionally, integrated workflows foster collaboration by offering shareable dashboards and the ability to add annotations, which facilitate actionable, data-driven insights. The platform allows for the analysis of data from various sources, encompassing both laboratory settings and external environments, ultimately leading to improved decision-making and outcomes in healthcare. By harnessing these capabilities, organizations can significantly elevate their operational standards and patient care quality.

When compared to other Electronic Data Capture (EDC) solutions available from companies like MediData, DataTrack, and Omnicomm, TrialStat stands out as the most comprehensive suite of study management tools that can effortlessly integrate with various external data sources, including electronic medical records (EMR), wearable devices, and both clinical and non-clinical information systems. TrialStat presents a cohesive platform that caters to all phases and categories of clinical trials. Our EDC suite is designed with a single sign-on feature and supports multiple tenants, incorporating modules for Randomization, Adjudication, Coding, Safety, Patient Diaries/ePRO, a Vendor Neutral Imaging Archive, an extensive Reporting and Analytics Portal, and tailored Machine Learning applications. With an emphasis on data analysis, TrialStat provides real-time reporting capabilities, on-demand data extracts, and analytics that span a single study, a program, or the entirety of your research portfolio, ensuring that all stakeholders receive pertinent, customized, and timely insights into every facet of study data while pinpointing areas of risk or potential delays. Additionally, the platform’s integration capabilities allow for improved collaboration among research teams, fostering a more efficient and effective trial management experience.

RealTime-CTMS stands out as a leading, cloud-driven clinical trial management system designed specifically to enhance both efficiency and profitability for research sites and site networks. It features a suite of fully-integrated services, such as RealTime-PAY, RealTime-TEXT, and RealTime-eDOCS, which is the first fully-integrated eRegulatory document management system, facilitating faster and easier access to study or subject information through a user-friendly interface. In addition to these offerings, RealTime-CTMS provides a variety of other solutions, including online document storage, appointment reminders, data collection, and payment processing, ensuring comprehensive support for clinical trial management. This extensive array of features makes RealTime-CTMS an invaluable tool for improving the overall workflow within clinical research environments.

BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.

Biorce’s Aika represents a groundbreaking AI-driven clinical intelligence platform that enhances every phase of the clinical trial lifecycle by transforming slow, manual processes for protocol development and feasibility assessments into efficient, evidence-based automation. Leveraging insights from approximately one million real-world trials, Aika can swiftly produce first-draft study protocols, comprehensive regulatory documentation, site feasibility evaluations, risk management strategies, and other critical trial components significantly faster than conventional approaches, which helps in minimizing delays and expensive modifications. Aika not only ensures complete transparency in its recommendation processes, allowing teams to confidently communicate their decisions to regulators while retaining expert oversight, but also effectively combines the rapid capabilities of AI with the depth of clinical knowledge. By drastically reducing trial preparation times from weeks to mere days, it significantly decreases the chances of amendments and mitigates overall risk, all while seamlessly fitting into existing workflows without the need for extensive retraining. With Aika, clinical trial teams can focus more on strategic decision-making rather than being bogged down by administrative tasks.

Business intelligence in the global biopharmaceutical sector focuses on drug patent dynamics and the entry of generics. It is essential to forecast future budget needs and proactively seek out generic alternatives. Analyzing the achievements of past patent challengers provides insights into the competitive landscape and informs research directions. This analysis plays a crucial role in guiding portfolio management strategies for upcoming drug development projects. Additionally, anticipating the expiration of patents on branded drugs, pinpointing potential generic suppliers, and managing branded drug inventory effectively are vital. Furthermore, acquiring detailed formulation and manufacturing data helps in identifying key formulators, repackagers, and relabelers to streamline operations and enhance market positioning. Understanding these elements can significantly bolster strategic decision-making in the biopharmaceutical industry.

Discover a comprehensive platform designed for researching, documenting, and organizing your clinical data seamlessly. The Nucleus platform streamlines your research data management, providing a unified space for storing study documentation, clinical datasets, submission materials, and compliant media. With Nucleus Documents, you can efficiently manage documents and maintain version control for your quality documentation and media assets. Easily oversee, manage, and share your organizational content without hassle. Additionally, effortlessly compile and regulate your electronic trial master file documents through our centralized regulatory document management system. Nucleus Coding facilitates dictionary term coding for both MedDRA and WHODrug dictionaries, available as a standalone application or integrated within your data capture system, ensuring flexibility and efficiency in your coding processes. This comprehensive solution not only enhances data integrity but also optimizes collaboration across your research teams.

Streamlined surveillance of diverse data sources, seamlessly integrated with a GVP IX compliant signal management platform, can revolutionize your safety data handling. The Evidex platform offers a ready-to-go, GVP-IX compliant signal management solution that simplifies your operations without the hassle of switching between various services. By modernizing your management processes, you can ensure they are audit-proof and efficient. This automation not only helps meet regulatory standards but also enhances the overall value generated for your organization. With automated signal detection, you can identify safety signals from established sources such as ICSR databases, the FDA's Adverse Event Reporting System (FAERS), VigiBase, and clinical trial data. Furthermore, you can incorporate additional data sources, including claims, electronic health records (EHR), and other unstructured information. By aggregating these diverse data pools, you can significantly improve signaling algorithms, streamline validations and assessments, and accelerate responses to pressing drug safety inquiries. Ultimately, this approach transforms how organizations manage and leverage safety data for better outcomes.

Omda MedSciNet solutions enhance the quality, usability, and administration of medical data throughout its lifecycle from collection to analysis. This secure and standardized software streamlines the process for clinical researchers and other professionals in healthcare and academia, allowing for the efficient gathering and examination of well-organized medical data. The dedicated Omda team excels in the development and management of customized database applications, as well as designing clinical studies tailored for medical research and quality registries. The Omda MedSciNet study platform offers a dependable, feature-rich, and highly adaptable online environment suitable for hosting and managing complex study and clinical trial systems. With a proven track record spanning 20 years, Omda MedSciNet has effectively supported studies and clinical trials of various scopes and sizes. Standard implementations come equipped with a comprehensive array of components essential for launching fully functional studies or clinical trials, ensuring that researchers have all the necessary tools at their disposal. This commitment to quality and customization positions Omda MedSciNet as a leader in the field of medical data management.